Publications
RECENT PUBLICATIONS
Phase 1 Dose Expansion Results of CYT-0851, a Monocarboxylate Transporter (MCT) Inhibitor, in Combination with Capecitabine in Platinum-Resistant Ovarian Cancer
Lynch, R.C., et.al., AACR-NCI-EORTC 2023
VIEW PUBLICATION →Phase 1 Results of CYT-0851, a Monocarboxylate Transporter (MCT) Inhibitor, in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors
Lynch, R.C., et.al., ASCO 2023
VIEW PUBLICATION →Phase 1 Results of CYT-0851 in Patients with Advanced Solid and Hematologic Cancers
Lynch, R.C., et.al., ASCO 2022
VIEW PUBLICATION →Identification of the Mechanism of Action of CYT-0851, An Inhibitor of Monocarboxylate Transporter (MCT) Mediated Lactate Transport
Bradley, W.D., et.al., 34th EORTC-NCI-AACR Symposium 2022
VIEW PUBLICATION →First-in-Human Phase I/II Study of CYT-0851 in Patients with Advanced Solid and Hematologic
Lynch, R.C., et.al., ASCO 2021
VIEW PUBLICATION →